OBJECTIVE: As prostate-specific antigen (psa) makes prostate cancer (pca) screening more accessible, more men are being identified with conditions that indicate high risk for developing pca, such as elevated psa and high-grade intraepithelial neoplasia (hgpin). In the present study, we assessed psychological well-being and risk perception in individuals with those high-risk conditions. METHODS: A questionnaire consisting of a psychological symptom survey, a trait risk-aversion survey, and a cancer-specific risk perception survey was administered to 168 patients with early-stage localized pca and 69 patients at high risk for pca (n = 16 hgpin, n = 53 psa > 4 ng/mL). Analysis of variance was used to examine differences in psychological well-being and appraisal of risk between the groups. RESULTS: Compared with the pca group, the high-risk group perceived their risk of dying from something other than pca to be significantly lower (p = 0.007). However, pca patients reported significantly more clinically important psychological symptoms. CONCLUSIONS: The identification of prostate conditions that predict progression to cancer might not result in the psychological symptoms commonly experienced by pca patients, but does appear to be related to a distorted perception of the disease's mortal risk. Patients with pca experience reduced psychological well-being, but better understand the risks of pca recurrence and death. Education on the risks and outcomes of pca can help at-risk men to view health assessments with reduced worry.
OBJECTIVE: As prostate-specific antigen (psa) makes prostate cancer (pca) screening more accessible, more men are being identified with conditions that indicate high risk for developing pca, such as elevated psa and high-grade intraepithelial neoplasia (hgpin). In the present study, we assessed psychological well-being and risk perception in individuals with those high-risk conditions. METHODS: A questionnaire consisting of a psychological symptom survey, a trait risk-aversion survey, and a cancer-specific risk perception survey was administered to 168 patients with early-stage localized pca and 69 patients at high risk for pca (n = 16 hgpin, n = 53 psa > 4 ng/mL). Analysis of variance was used to examine differences in psychological well-being and appraisal of risk between the groups. RESULTS: Compared with the pca group, the high-risk group perceived their risk of dying from something other than pca to be significantly lower (p = 0.007). However, pca patients reported significantly more clinically important psychological symptoms. CONCLUSIONS: The identification of prostate conditions that predict progression to cancer might not result in the psychological symptoms commonly experienced by pca patients, but does appear to be related to a distorted perception of the disease's mortal risk. Patients with pca experience reduced psychological well-being, but better understand the risks of pca recurrence and death. Education on the risks and outcomes of pca can help at-risk men to view health assessments with reduced worry.
Authors: O Bratt; J E Damber; M Emanuelsson; U Kristoffersson; R Lundgren; H Olsson; H Grönberg Journal: Eur J Cancer Date: 2000-01 Impact factor: 9.162
Authors: David A Katz; David F Jarrard; Colleen A McHorney; Stephen L Hillis; Donald A Wiebe; Dennis G Fryback Journal: Urology Date: 2007-02 Impact factor: 2.649
Authors: R C Macefield; C Metcalfe; J A Lane; J L Donovan; K N L Avery; J M Blazeby; L Down; D E Neal; F C Hamdy; K Vedhara Journal: Br J Cancer Date: 2010-04-06 Impact factor: 7.640
Authors: Jennifer L Beebe-Dimmer; David P Wood; Stephen B Gruber; Doug M Chilson; Kimberly A Zuhlke; Gina B Claeys; Kathleen A Cooney Journal: Cancer Date: 2004-04-01 Impact factor: 6.860
Authors: E M Wever; E A M Heijnsdijk; G Draisma; C H Bangma; M J Roobol; F H Schröder; H J de Koning Journal: Br J Cancer Date: 2013-05-14 Impact factor: 7.640